Long-Established Manhattan Plastic Surgery Practice, 30-Year New York Operator

$3.0M

Revenue

$680K

SDE

Subscribe Free

Read the full deal writeup

Get Free Access

Already a member? Sign in

Full Editorial Writeup

This is a nearly 30-year-old plastic surgery practice operating in Manhattan with a satellite location near Westchester. The practice generated roughly $2.98M in 2025 collections and more than $680K in seller's discretionary earnings, serving approximately 1,025 patients annually with 45 to 50 new patients arriving each month. The 4,500 square foot main facility houses two operating rooms, two exam rooms, and two treatment rooms, and is equipped with VASER, DEKA laser, CoolSculpting, CoolTone, Vivace RF microneedling, and Vectra imaging technology.

The practice sits in one of the most competitive and prestigious cosmetic surgery markets in the country, where reputation, surgeon credentials, and patient experience are the primary differentiators. Its edge is longevity: three decades of operating history, an established patient base, and durable market recognition are things a new entrant cannot buy or build quickly. Both surgical and non-surgical service lines are in place, giving a buyer multiple revenue levers rather than a single-procedure dependency.

The positioning suits a surgeon-buyer, a physician group, or a strategic aesthetics platform seeking entry or expansion in New York. The obvious constraint is that this is a personal-goodwill business tied to a practicing surgeon, so the real question for any buyer is how much of that $680K SDE survives the transition when the founding surgeon steps back.

Why we like it

The practice throws off $680K in SDE on $2.98M in collections, roughly a 23 percent owner-earnings margin, which is healthy for a service practice carrying two operating rooms and a satellite. That earnings base is built on a real patient flow of about 1,025 patients a year and a steady 45 to 50 new patients monthly, not on a single blockbuster season.
Nearly 30 years of operating history in Manhattan is the moat here. In a market where credentials, outcomes, and word of mouth decide who gets the patient, an established brand and referral engine is far harder to replicate organically than any piece of laser equipment.
Manhattan concentrates a large population of affluent consumers accustomed to paying cash for premium aesthetic services, and demand extends to destination patients traveling in for procedures. The competitive intensity of the market is itself evidence of the underlying spend available to a practice that already has recognition.
The infrastructure is already built and paid into: two ORs, exam and treatment rooms, and a full non-surgical technology stack including CoolSculpting, VASER, DEKA laser, and Vectra imaging. A buyer inherits capacity that is currently underutilized, so incremental surgical and aesthetic volume can flow through fixed overhead at attractive margins.

How to improve it

Add associate surgeon or advanced-provider coverage to lift consultation and surgical capacity without building a new Manhattan presence. The listing flags that current infrastructure is underutilized, so every added provider hour converts fixed rent and equipment cost into contribution margin.
Push the non-surgical service lines harder to build repeatable revenue. CoolSculpting, CoolTone, Vivace RF microneedling, and skin rejuvenation lend themselves to maintenance packages and memberships that bring the same patient back multiple times a year rather than once for a single procedure.
Install a structured patient reactivation and conversion program against the existing database. With 45 to 50 new consults arriving monthly and 30 years of past patients on file, tightening consult-to-procedure conversion and re-engaging dormant patients is the fastest revenue with the lowest acquisition cost.
Invest in digital marketing, reviews, and referral development to feed the Westchester satellite. The satellite is an existing but likely under-marketed asset, and targeted campaigns to the suburban metro market could grow volume without cannibalizing the Manhattan flagship.
Standardize the surgical and aesthetic offering into defined treatment plans and price bundles so the practice sells integrated packages instead of one-off procedures. This raises average revenue per patient and smooths the mix between high-ticket surgery and recurring maintenance services.
Formalize the surgeon transition and de-risk personal goodwill by recruiting and branding a successor surgeon early. The single biggest value driver is retaining the patient trust that currently attaches to the founder, so a documented, patient-facing handover protects the SDE a buyer is paying for.
Tighten payer and collections operations around the cash-pay elective mix. Because these are largely discretionary out-of-pocket procedures, financing options and clean up-front collections directly affect conversion and cash flow, and a modern point-of-sale financing partner can lift close rates.

Diligence notes

Quantify how much of the $680K SDE is personal-goodwill tied to the founding surgeon versus transferable to a buyer's team. Ask what portion of surgical revenue the current owner personally performs, and model the earnings under a scenario where that surgeon departs within 12 months.
Break the $2.98M collections into surgical versus non-surgical and cash-pay versus insurance. Elective cosmetic revenue is discretionary and cyclical, so understanding the mix and its trend over the last three years tells you how durable the top line really is through a downturn.
Verify the 2025 collections figure against actual bank deposits and tax returns, and confirm whether $2.98M is collections or billings. Also confirm the SDE add-backs, since practices with a working owner-surgeon often overstate discretionary earnings by adding back compensation that a replacement surgeon must actually be paid.
Review the leases on both the 4,500 square foot Manhattan facility and the Westchester satellite, including term, escalations, and assignability. Manhattan medical rent is a material fixed cost, and an expiring or unfavorable lease could swamp the margin advantage of the existing infrastructure.
Confirm the condition, age, and remaining service life of the equipment stack (VASER, DEKA, CoolSculpting, CoolTone, Vivace, Vectra) and whether any is leased or financed. Aesthetic devices carry consumable and service-contract costs, and near-term replacement capex could erode the earnings picture.
Diligence provider credentials, malpractice history, licensing, and OR accreditation for both locations. In a reputation-driven cosmetic market any regulatory, licensing, or litigation exposure is an existential risk to the brand value you are buying.

Source

Originally listed on BizBuySell. View original listing →